EVH (Evolent Health) Equity-to-Asset: 0.19 (As of Jun. 2026) — 60% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EVH Evolent Health Inc EVH
66 GF Score
Price $4.82
GF Value $10.11
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Evolent Health Equity-to-Asset?

Evolent Health EVH +2.12% 66 Equity-to-Asset is 0.19 as of Jun. 2026, which is 60% below its 10-year median of 0.48. GuruFocus rates EVH with a GF Score™ of 66/100 and a GF Value™ of $10.11 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 685 Healthcare Providers & Services companies, Evolent Health ranks worse than 82.92% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Evolent Health's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $383 Mil. Evolent Health's Total Assets for the quarter that ended in Jun. 2026 was $1,972 Mil. Therefore, Evolent Health's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.19.

The historical rank and industry rank for Evolent Health's Equity-to-Asset or its related term are showing as below:

EVH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.19   Med: 0.48   Max: 0.8
Current: 0.19

During the past 13 years, the highest Equity to Asset Ratio of Evolent Health was 0.80. The lowest was 0.19. And the median was 0.48.

EVH's Equity-to-Asset is ranked worse than
82.92% of 685 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs EVH: 0.19

Evolent Health  (NYSE:EVH) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Evolent Health Equity-to-Asset Related Terms


Evolent Health Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Evolent Health's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolent Health Equity-to-Asset Chart

Evolent Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.49 0.47 0.40 0.39 0.22

Evolent Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.34 0.22 0.21 0.19

EVH vs NRC, SOPH, WEAV: Equity-to-Asset Comparison

For the Health Information Services subindustry, Evolent Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolent Health Equity-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Evolent Health's Equity-to-Asset falls into.


EVH
66GF Score
Evolent Health Inc EVH
Equity-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolent Health Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Evolent Health's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Equity to Asset (A: Dec. 2025 )=Total Stockholders Equity/Total Assets
=415.194/1899.236
=0.22

Evolent Health's Equity to Asset Ratio for the quarter that ended in Jun. 2026 is calculated as

Equity to Asset (Q: Jun. 2026 )=Total Stockholders Equity/Total Assets
=383.223/1971.894
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of 0.19 mean?
Evolent Health (EVH) has a Equity-to-Asset of 0.19 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Evolent Health and its competitors. This is 60% below median its historical median of 0.48. Over the past decade, Evolent Health's Equity-to-Asset has ranged from 0.19 to 0.80. According to the industry distribution chart, Evolent Health ranks #568 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 82.9%.
Is Evolent Health's Equity-to-Asset too high?
Evolent Health's current Equity-to-Asset of 0.19 is 60% below median its 10-year median of 0.48. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 0.80. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Evolent Health's value of 0.19 is 60.4% below this industry median. Based on the distribution chart, Evolent Health ranks #568 out of 685 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Evolent Health has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Equity-to-Asset compare to NRC and SOPH?
According to the Healthcare Providers & Services industry distribution chart, Evolent Health ranks #568 out of 685 companies for Equity-to-Asset. This places Evolent Health in the lower half of its industry. The industry median Equity-to-Asset is 0.48. Evolent Health's value of 0.19 is 60.4% below this benchmark. Historically, Evolent Health's own Equity-to-Asset has ranged from 0.19 to 0.80 over the past decade. While the company's 10-year median is 0.48 vs. the industry median of 0.48, Evolent Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evolent Health's current Equity-to-Asset of 0.19 is 60.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Evolent Health and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evolent Health's current Equity-to-Asset is 0.19, which is 60% below median its own 10-year median of 0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $10.11, compared to a current price of $4.82 — trading 52.3% below its estimated fair value. The current Equity-to-Asset is 0.19, which is 60% below median its 10-year median of 0.48 and 60.4% below the Healthcare Providers & Services industry median of 0.48. Evolent Health's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Evolent Health (EVH), the current Equity-to-Asset is 0.19 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evolent Health (EVH) Overvalued in 2026?

Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued. The current stock price of $4.82 is trading 52.3% below its estimated GF Value™ of $10.11. GuruFocus considers Evolent Health to be Possible Value Trap.

Key valuation signals for EVH:

  • Equity-to-Asset: 0.19 (60% below median its 10-year median of 0.48)
  • GF Value™: $10.11 vs. price of $4.82 (52.3% below fair value)
  • GF Score™: 66/100 with 6 warning signs
  • Industry Position: 60.4% below the Healthcare Providers & Services median (#568 of 685)

No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Evolent Health Business Description

Other Exchanges 9EH:Germany
Address 1812 North Moore Street, Suite 1705, Arlington, VA, USA, 22209
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
66GF Score

Get the complete analysis for EVH

Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.82
Price
$10.11
GF Value